{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:49:25Z","timestamp":1754153365585,"version":"3.41.2"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["PALMER19AB0"],"award-info":[{"award-number":["PALMER19AB0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01AI113315","2T32AI052077-16A1"],"award-info":[{"award-number":["U01AI113315","2T32AI052077-16A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jhlto.2024.100113","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T02:47:02Z","timestamp":1716864422000},"page":"100113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluating longitudinal cytomegalovirus-specific humoral immune responses and association with DNAemia risk in seropositive lung transplant recipients"],"prefix":"10.1016","volume":"5","author":[{"given":"Melissa J.","family":"Harnois","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Barfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Pollara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connor S.","family":"Spies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie D.","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cliburn","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sallie R.","family":"Permar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhlto.2024.100113_bib1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics"},{"key":"10.1016\/j.jhlto.2024.100113_bib2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40265-018-0943-1","article-title":"New developments in the management of cytomegalovirus infection after transplantation","volume":"78","author":"Meesing","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.jhlto.2024.100113_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.athoracsur.2018.10.034","article-title":"Long-term impact of cytomegalovirus serologic status on lung transplantation in the United States","volume":"107","author":"Kurihara","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jhlto.2024.100113_bib4","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1128\/jvi.67.9.5360-5366.1993","article-title":"Lungs are a major organ site of cytomegalovirus latency and recurrence","volume":"67","author":"Balthesen","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.jhlto.2024.100113_bib5","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MOT.0000000000000753","article-title":"Survival in adult lung transplantation: where are we in 2020?","volume":"25","author":"Bos","year":"2020","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jhlto.2024.100113_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.bpa.2017.05.006","article-title":"Long-term outcomes and management of lung transplant recipients","volume":"31","author":"Costa","year":"2017","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"10.1016\/j.jhlto.2024.100113_bib7","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.healun.2021.05.011","article-title":"Association between chronic lung allograft dysfunction and human Cytomegalovirus UL40 peptide variants in lung-transplant recipients","volume":"40","author":"Vietzen","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2024.100113_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13512","article-title":"Cytomegalovirus in solid organ transplant recipients-guidelines of the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Razonable","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhlto.2024.100113_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13069","article-title":"Cytomegalovirus viremia in lung transplantation during and after prophylaxis","volume":"21","author":"Chang","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jhlto.2024.100113_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ctr.12686","article-title":"Cytomegalovirus disease is associated with higher all-cause mortality after lung transplantation despite extended antiviral prophylaxis","volume":"30","author":"Beam","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhlto.2024.100113_bib11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/TP.0b013e3182115ba2","article-title":"Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment","volume":"91","author":"Benmarzouk-Hidalgo","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jhlto.2024.100113_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3324\/haematol.11912","article-title":"Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection","volume":"93","author":"Lilleri","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.jhlto.2024.100113_bib13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhlto.2024.100113_bib14","first-page":"2","article-title":"Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: a clinical update","volume":"11","author":"Prakash","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jhlto.2024.100113_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00043-19","article-title":"Progress and challenges in the prevention, diagnosis, and management of cytomegalovirus infection in transplantation","volume":"34","author":"Limaye","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jhlto.2024.100113_bib16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/ajt.15957","article-title":"Highlights from the clinical trials in organ transplantation (CTOT)-20 and CTOT-22 Consortium studies in lung transplant","volume":"20","author":"Snyder","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhlto.2024.100113_bib17","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/infdis\/jiac341","article-title":"Characterization of plasma immunoglobulin G responses in elite neutralizers of human cytomegalovirus","volume":"226","author":"Harnois","year":"2022","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhlto.2024.100113_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jhlto.2024.100113_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jhlto.2024.100113_bib20","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhlto.2024.100113_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.jhlto.2024.100113_bib22","unstructured":"Mangiafico S.rcompanion: Functions to support extension education program evaluation. R package version 2.4.1; 2021."},{"year":"2008","series-title":"Applied Econometrics with R","author":"Kleiber","key":"10.1016\/j.jhlto.2024.100113_bib23"},{"key":"10.1016\/j.jhlto.2024.100113_bib24","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhlto.2024.100113_bib25","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/infdis\/jiz454","article-title":"Cytomegalovirus infection in solid organ and hematopoietic cell transplantation: state of the evidence","volume":"221","author":"Haidar","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhlto.2024.100113_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcv.2007.10.006","article-title":"Donor and recipient CMV serostatus and antigenemia after renal transplantation: an analysis of 486 patients","volume":"41","author":"Hughes","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jhlto.2024.100113_bib27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.healun.2023.02.1652","article-title":"Longitudinal dynamics of SARS-CoV-2 spike-specific antibody responses in patients on waiting list and after lung transplantation","volume":"42","author":"H\u00fcbner","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2024.100113_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/infdis\/jiaa097","article-title":"Human cytomegalovirus (HCMV)-specific antibody response and development of antibody-dependent cellular cytotoxicity against HCMV after lung transplantation","volume":"222","author":"Vietzen","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhlto.2024.100113_bib29","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jhlto.2024.100113_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/JCI156827","article-title":"Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection","volume":"132","author":"Semmes","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jhlto.2024.100113_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22158206","article-title":"Analysis and fine specificity of the HCMV-specific cell-free and cell-associated antibody-dependent cellular phagocytosis (ADCP) responses in lung transplant recipients","volume":"22","author":"Eberhard","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jhlto.2024.100113_bib32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/infdis\/jiaa727","article-title":"CMV-specific cell-mediated immunity predicts a high level of CMV replication after prophylaxis withdrawal in lung transplant recipients","volume":"224","author":"Donadeu","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhlto.2024.100113_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1164\/rccm.201504-0733OC","article-title":"Polyfunctional T-cell signatures to predict protection from cytomegalovirus after lung transplantation","volume":"193","author":"Snyder","year":"2016","journal-title":"Am J Respir Crit Care Med"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133424000624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133424000624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:28:29Z","timestamp":1753230509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133424000624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":33,"alternative-id":["S2950133424000624"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2024.100113","relation":{},"ISSN":["2950-1334"],"issn-type":[{"type":"print","value":"2950-1334"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating longitudinal cytomegalovirus-specific humoral immune responses and association with DNAemia risk in seropositive lung transplant recipients","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2024.100113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100113"}}